Company intelligence / Profile preview

Boxer Capital

San Diego, California, United Statesboxercap.com ↗

Ownership: Private
Employees: ~21
Development stage: Other

Overview

Boxer Capital is not a drug development company but an investment fund. It has invested in over 74 private biotech companies since 2014 and participated in more than 51 liquidity events such as IPOs or acquisitions. Its portfolio spans early discovery through late clinical and commercial stages with a focus on transformative medical advancements in precision medicine.

Therapeutic areas: OncologyCardiovascularNeurology
Modalities: Small moleculeMonoclonal antibodyAntibody-drug conjugateGene therapyRNA therapy
Industry: Investors

Partnerships

Boxer partners with numerous biotech firms through its investments but does not typically form traditional R&D partnerships like operating biotechs.

Beyond the preview

Go deeper on Boxer Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Boxer Capital.

Explore the full profile